Abstract
Purpose
The purpose of study was to examine the relationship between obesity and its associated factors (psychiatric symptom, duration of illness, type of medication, physical activity, dietary habits, depressive symptom, and stress) in patients with chronic mental illness registered to community mental health welfare centers.
Methods
This was a cross-sectional correlation study using a convenience sampling. A total of 392 participants were recruited from community mental health welfare centers. The obtained data were analyzed using binary and multinomial logistic regression.
References
1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization;2010.
2. Korea Centers for Disease Control and Prevention. Korea health statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1). Osong: Ministry of Health and Welfare;2014. Report No. 11-1351159-000027-10.
3. Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. The Journal of Nervous and Mental Disease. 2003; 191(12):799–805. https://doi.org/10.1097/01.nmd.0000100923.20188.2d.
4. Hert MD, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011; 10(1):52–77. https://doi.org/10.1002/j.2051-5545.2011.tb00014.x.
5. Homel P, Casey D, Allison DB. Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophrenia Research. 2002; 55(3):277–284. https://doi.org/10.1016/s0920-9964(01)00256-0.
6. Kim Y, Cho BL, Park JH, Shin DY, Park JH, Oh MK, et al. A study of prevalence of obesity and policy development for reducing obesity among people with disabilities in Korea. Seoul: Seoul National University;2011. February. Report No. 11-1352 000-000218-14.
7. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. The British Journal of Psychiatry. 2010; 196(2):116–121. https://doi.org/10.1192/bjp.bp.109.067512.
8. Limosin F, Gasquet I, Leguay D, Azorin JM, Rouillon F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatrica Scandinavica. 2008; 118(1):19–25. https://doi.org/10.1111/j.1600-0447.2008.01208.x.
9. Cerimele JM, Katon WJ. Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: A systematic review. General Hospital Psychiatry. 2013; 35(1):16–22. https://doi.org/10.1016/j.genhosppsych.2012.08.001.
10. Rivenes AC, Harvey SB, Mykletun A. The relationship between abdominal fat, obesity, and common mental disorders: Results from the HUNT Study. Journal of Psychosomatic Research. 2009; 66(4):269–275. https://doi.org/10.1016/j.jpsychores.2008.07.012.
11. Kim LJ. Predictive factors of weight gain during the early period of treatment with atypical antipsychotics [master's thesis]. Gwangju: Chonnam National University;2012. p. 31.
12. Im HS, Han KS, Chung HK. Effects of weight control program on weight gain and self esteem of psychiatric inpatients. Journal of Korean Academy of Psychiatric and Mental Health Nursing. 2006; 15(1):5–13.
13. Hong MN, Baek GS, Han YH, Kwon MS. Effects of weight control program on body weight and the sense of efficacy for control of dietary behavior of psychiatric inpatients. Journal of Korean Academy of Nursing. 2008; 38(4):533–540. https://doi.org/10.4040/jkan.2008.38.4.533.
14. Kim SY, Kim SJ. Effects of weight reduction program on body weight, self esteem and efficacy of chronic mentally ill persons. Journal of Korean Public Health Nursing. 2015; 29(3):594–607. https://doi.org/10.5932/JKPHN.2015.29.3.594.
15. Hsieh FY. Sample size tables for logistic regression. Statistics in Medicine. 1989; 8(7):795–802. https://doi.org/10.1002/sim.4780080704.
16. Steering Committee. The Asia-pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications Australia;2000. p. 55.
17. Overall JE, Hollister LE, Pichot P. Major psychiatric disorders: A four-dimensional model. Archives of General Psychiatry. 1967; 16(2):146–151. https://doi.org/10.1001/archpsyc.1967.01730200014003.
18. Kim MK, Lee BK, Jeon YW. Reliability of Korean Brief Psychiatric Rating Scale (BPRS) - Comparison of interrater reliability between the two rating methods and correlation of BPRS and SCL-90 self-report test. The Korean Journal of Clinical Psychology. 2003; 22(3):685–698.
19. Godin G. The Godin-Shephard leisure-time physical activity questionnaire. Health & Fitness Journal of Canada. 2011; 4(1):18–22.
20. Kim YH, Cardinal BJ, Lee JY. Understanding exercise behavior among Korean adults: A test of the transtheoretical model. International Journal of Behavioral Medicine. 2006; 13(4):295–303. https://doi.org/10.1207/s15327558ijbm1304_4.
21. Jo JS, Kim KN. Development of a questionnaire for dietary habit survey of Korean adults. Korean Journal of Community Nutrition. 2014; 19(3):258–273. https://doi.org/10.5720/kjcn.2014.19.3.258.
22. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Journal of the American Medical Association. 1999; 282(18):1737–1744. https://doi.org/10.1001/jama.282.18.1737.
23. An JY, Seo ER, Lim KH, Shin JH, Kim JB. Standardization of the Korean version of screening tool for depression (Patient Health Questionnaire-9, PHQ-9). Journal of the Korean Society of Biological Therapies in Psychiatry. 2013; 19(1):47–56.
24. Frank SH, Zyzanski SJ. Stress in the clinical setting: The Brief Encounter Psychosocial Instrument. The Journal of Family Practice. 1988; 26(5):533–539.
25. Yim JH, Bae JM, Choi SS, Kim SW, Hwang HS, Huh BY. The validity of modified Korean-translated BEPSI (Brief Encounter Psychosocial Instrument) as instrument of stress measurement in outpatient clinic. Korean Journal of Family Medicine. 1996; 17(1):42–49.
26. Bustillo JR, Buchanan RW, Irish D, Breier A. Differential effect of clozapine on weight: A controlled study. The American Journal of Psychiatry. 1996; 153(6):817–819. https://doi.org/10.1176/ajp.153.6.817.
27. Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia. The Journal of Clinical Psychiatry. 2001; 62(2):92–100. https://doi.org/10.4088/jcp.v62n0204.
28. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychological Medicine. 1999; 29(3):697–701. https://doi.org/10.1017/s0033291798008186.
Table 1.
Characteristics | Categories | n (%) | BMI obesity | Abdominal obesity | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Normal | Overweight | Obesity | Severe obesity | x2 (p) | Normal | Obesity | x2 (p) | |||
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||
Gender | Male | 234 (59.7) | 59 (25.2) | 67 (28.6) | 77 (32.9) | 31 (13.2) | 10.88 | 97 (41.5) | 137 (58.5) | 19.20 |
Female | 158 (40.3) | 54 (34.2) | 25 (15.8) | 50 (31.6) | 29 (18.4) | (.012) | 32 (20.3) | 126 (79.7) | (<.001) | |
Age (year) | ≤29 | 47 (12.0) | 22 (46.8) | 8 (17.0) | 9 (19.1) | 8 (17.0) | 13.03 | 28 (59.6) | 19 (40.4) | 19.65 |
30~39 | 95 (24.2) | 22 (23.2) | 26 (27.4) | 30 (31.6) | 17 (17.9) | (.161) | 32 (33.7) | 63 (66.3) | (<.001) | |
40~49 | 126 (32.2) | 31 (24.6) | 30 (23.8) | 46 (36.5) | 19 (15.1) | 39 (31.0) | 87 (69.0) | |||
≥50 | 124 (31.6) | 38 (30.6) | 28 (22.6) | 42 (33.9) | 16 (12.9) | 30 (24.2) | 84 (75.8) | |||
Education level | Elementary school | 35 (8.9) | 7 (20.0) | 10 (28.6) | 14 (40.0) | 4 (11.4) | 5.56 | 7 (20.0) | 28 (80.0) | 3.39 |
Middle school | 58 (14.8) | 15 (25.9) | 17 (29.3) | 17 (29.3) | 9 (15.5) | (.783) | 18 (31.0) | 40 (69.0) | (.335) | |
High school | 220 (56.2) | 68 (30.9) | 44 (20.0) | 72 (32.7) | 4 (11.4) | 78 (35.5) | 142 (64.5) | |||
≥College Missing | 2 (0.5) | 23 (29.9) | 20 (26.0) | 23 (29.9) | 11 (14.3) | 25 (32.5) | 52 (67.5) | |||
Marital status | Single | 284 (72.4) | 85 (29.9) | 67 (23.6) | 95 (33.5) | 37 (13.0) | 8.59 | 104 (36.6) | 180 (63.4) | 8.06 |
Married | 42 (11.0) | 8 (18.6) | 8 (18.6) | 17 (39.5) | 10 (23.3) | (.198) | 13 (30.2) | 30 (69.8) | (.018) | |
Divorced | 65 (16.6) | 20 (30.8) | 17 (26.2) | 15 (23.1) | 13 (20.0) | 12 (18.5) | 53 (81.5) | |||
Monthly income (10,000 won) | <100 | 239 (61.0) | 66 (27.6) | 59 (24.7) | 81 (33.9) | 33 (13.8) | 2.23 (.527) | 75 (31.4) | 164 (68.6) | 0.65 |
≥100 | 150 (38.2) | 46 (30.7) | 33 (22.0) | 44 (29.3) | 27 (18.0) | (.527) | 53 (35.3) | 97 (64.7) | (.419) | |
Missing | 3 (0.8) | |||||||||
Health insurance status | Health insurance | 216 (55.1) | 60 (27.8) | 51 (23.6) | 69 (31.9) | 36 (16.7) | 0.80 | 75 (34.7) | 141 (65.3) | 0.72 |
Medical aid | 176 (44.9) | 53 (30.1) | 41 (23.3) | 58 (33.0) | 24 (13.6) | (.849) | 54 (30.7) | 122 (69.3) | (.397) | |
Smoking | No smoking | 248 (63.3) | 75 (30.2) | 53 (21.4) | 82 (33.1) | 38 (15.3) | 1.83 | 74 (29.8) | 174 (70.2) | 2.88 |
Smoking | 144 (36.7) | 38 (26.4) | 39 (27.1) | 45 (31.3) | 22 (15.3) | (.609) | 55 (38.2) | 89 (61.8) | (.090) | |
Alcohol | No drinking for a year | 262 (66.8) | 81 (30.9) | 60 (22.9) | 86 (32.8) | 35 (13.4) | 5.85 | 84 (32.1) | 178 (67.9) | 0.73 |
≤4 times/month | 108 (27.6) | 28 (25.9) | 27 (25.0) | 31 (28.7) | 22 (20.4) | (.440)† | 36 (33.3) | 72 (66.7) | (.694) | |
≥5 times/month | 22 (5.6) | 4 (18.2) | 5 (22.7) | 10 (45.5) | 3 (13.6) | 9 (40.9) | 13 (59.1) | |||
Diagnosis | Schizophrenia | 346 (88.3) | 96 (27.7) | 87 (25.1) | 110 (31.8) | 53 (15.3) | 6.29 | 112 (32.4) | 234 (67.6) | 1.16 |
Bipolar disorder | 20 (5.1) | 6 (30.0) | 2 (10.0) | 8 (40.0) | 4 (20.0) | (.391)† | 6 (30.0) | 14 (70.0) | (.559) | |
Depression | 26 (6.6) | 11 (42.3) | 3 (11.5) | 9 (34.6) | 3 (11.5) | 11 (42.3) | 15 (57.7) | |||
Drug compliance | Daily taking | 365 (90.8) | 101 (28.4) | 88 (24.7) | 115 (32.3) | 52 (14.6) | 4.11 | 119 (33.4) | 237 (66.6) | 0.47 |
Non daily taking | 36 (9.2) | 12 (33.3) | 4 (11.1) | 12 (33.3) | 8 (22.2) | (.250) | 10 (27.8) | 26 (72.2) | (.492) |